These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7510696)
1. Protein kinase A regulation of cAMP phosphodiesterase expression in rat skeletal myoblasts. Kovala T; Lorimer IA; Brickenden AM; Ball EH; Sanwal BD J Biol Chem; 1994 Mar; 269(12):8680-5. PubMed ID: 7510696 [TBL] [Abstract][Full Text] [Related]
2. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels. Rochais F; Vandecasteele G; Lefebvre F; Lugnier C; Lum H; Mazet JL; Cooper DM; Fischmeister R J Biol Chem; 2004 Dec; 279(50):52095-105. PubMed ID: 15466415 [TBL] [Abstract][Full Text] [Related]
3. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Naro F; Sette C; Vicini E; De Arcangelis V; Grange M; Conti M; Lagarde M; Molinaro M; Adamo S; Némoz G Mol Biol Cell; 1999 Dec; 10(12):4355-67. PubMed ID: 10588663 [TBL] [Abstract][Full Text] [Related]
4. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Erdogan S; Houslay MD Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416 [TBL] [Abstract][Full Text] [Related]
5. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease. Netherton SJ; Jimmo SL; Palmer D; Tilley DG; Dunkerley HA; Raymond DR; Russell JC; Absher PM; Sage EH; Vernon RB; Maurice DH Diabetes; 2002 Apr; 51(4):1194-200. PubMed ID: 11916944 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. Sette C; Conti M J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227 [TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo. Tilley DG; Maurice DH Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425 [TBL] [Abstract][Full Text] [Related]
8. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle. Murthy KS; Zhou H; Makhlouf GM Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons. Sasaki T; Kotera J; Omori K J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290 [TBL] [Abstract][Full Text] [Related]
10. New insight into the role of phosphodiesterase 3A in porcine oocyte maturation. Sasseville M; Côté N; Guillemette C; Richard FJ BMC Dev Biol; 2006 Oct; 6():47. PubMed ID: 17038172 [TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Palmer D; Tsoi K; Maurice DH Circ Res; 1998 May; 82(8):852-61. PubMed ID: 9576105 [TBL] [Abstract][Full Text] [Related]
12. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases. Friis UG; Jensen BL; Sethi S; Andreasen D; Hansen PB; Skøtt O Circ Res; 2002 May; 90(9):996-1003. PubMed ID: 12016266 [TBL] [Abstract][Full Text] [Related]
13. IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase. De Arcangelis V; Coletti D; Conti M; Lagarde M; Molinaro M; Adamo S; Nemoz G; Naro F Mol Biol Cell; 2003 Apr; 14(4):1392-404. PubMed ID: 12686596 [TBL] [Abstract][Full Text] [Related]
14. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456 [TBL] [Abstract][Full Text] [Related]
15. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. Liu H; Palmer D; Jimmo SL; Tilley DG; Dunkerley HA; Pang SC; Maurice DH J Biol Chem; 2000 Aug; 275(34):26615-24. PubMed ID: 10851231 [TBL] [Abstract][Full Text] [Related]
16. Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells. Takahashi SI; Nedachi T; Fukushima T; Umesaki K; Ito Y; Hakuno F; Van Wyk JJ; Conti M Biochim Biophys Acta; 2001 Jul; 1540(1):68-81. PubMed ID: 11476896 [TBL] [Abstract][Full Text] [Related]
17. The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Swinnen JV; Joseph DR; Conti M Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8197-201. PubMed ID: 2554303 [TBL] [Abstract][Full Text] [Related]
18. 7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells. Wagner B; Jakobs S; Habermeyer M; Hippe F; Cho-Chung YS; Eisenbrand G; Marko D Biochem Pharmacol; 2002 Feb; 63(4):659-68. PubMed ID: 11992633 [TBL] [Abstract][Full Text] [Related]
19. Src tyrosine kinase activity in rat thecal-interstitial cells and mouse TM3 Leydig cells is positively associated with cAMP-specific phosphodiesterase activity. Taylor CC; Limback D; Terranova PF Mol Cell Endocrinol; 1997 Jan; 126(1):91-100. PubMed ID: 9027367 [TBL] [Abstract][Full Text] [Related]
20. Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Vicini E; Conti M Mol Endocrinol; 1997 Jun; 11(7):839-50. PubMed ID: 9178744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]